Ads
related to: xifaxan manufacturer website- 1495 West 5th Avenue, Columbus, OH · Directions · (614) 486-7159
Search results
Results From The WOW.Com Content Network
Rifaximin, sold under the brand name Xifaxan among others, is a non-absorbable, broad-spectrum antibiotic mainly used to treat travelers' diarrhea. It is based on the rifamycin antibiotics family. Since its approval in Italy in 1987, it has been licensed in more than 30 countries for the treatment of a variety of gastrointestinal diseases like ...
According to the drug’s manufacturer, 100% of Medicare Part D beneficiaries have some coverage for Xifaxan for either use. Medicare may also cover rifaximin (Xifaxan) for traveler’s diarrhea ...
Medicare Advantage coverage for Xifaxan Medicare Advantage is a type of health insurance that private companies can offer. Every Medicare Advantage plan must include Original Medicare parts A and B.
On December 16, 2019, the company settled a shareholder class action lawsuit under Section 11 of the U.S. Securities Act of 1933, alleging the company misled investors about its business operations and financial performance, for approximately $1.21 billion. [105] [106] The company denied allegations of all wrongdoing as part of the settlement.
Actavis Generics [1] (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products.
The 15 drugs accounted for $41 billion, or 14%, of total Medicare Part D spending between Nov. 1, 2023, and Oct. 1, 2024.
Ads
related to: xifaxan manufacturer website- 1495 West 5th Avenue, Columbus, OH · Directions · (614) 486-7159
